Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results
Date:11/10/2010

onship with Perrigo.

For the nine months ended September 30, 2010, the Company's marketing and selling expenses decreased 8%, or $15,000, to $185,000 compared to $200,000 for the comparable period in 2009. This decrease was primarily due to a decrease in personnel- related expenses, advertising and tradeshow expenses, offset by an increase in sales brokerage related expenses associated with the planned distribution of the nutritional products.  

General and administrative expenses decreased 42%, or $1.4 million, to $1.9 million for the nine months ended September 30, 2010, compared to $3.3 million for the same period in 2009, primarily due to a reduction in personnel related costs through headcount reductions and reductions in executive compensation.

Research and development expenses decreased 61%, or $1.3 million, to $853,000 for the nine months ended September 30, 2010, compared to $2.2 million for the same period in 2009, primarily due to reductions in personnel and other expenses reflecting the deferral of development activities for certain product candidates.

The net loss for the nine months ended September 30, 2010, decreased 52%, or $2.7 million, to $2.4 million, compared with a net loss of $5.1 million for the same period in 2009. This decrease was primarily due to lower overall operating expenses.

About SCOLR Pharma:Based in Bothell, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented CDT platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425-368-1050 or visit http:
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
2. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
3. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
4. SCOLR Pharma, Inc. Licenses Dietary Supplements
5. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
6. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
7. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
8. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
9. Reportlinker Adds Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th edition
10. Reportlinker Adds Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition
11. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led by ... a premier and affordable laser tattoo removal experience with the ... focus is in providing high quality cosmetic services with cutting edge ... " Southern California has seen a dramatic ...
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... Colo., Jan. 12, 2012 Biosyntrx, Inc. CEO Ellen ... to the Biosyntrx Board of Directors.  Mr. Feher lives ... engineering with an MBA from the University Of Southern ... Biosyntrx strategic planning consultant for the past two years.  ...
... 2012 CVS Caremark Corporation will pay $5 million ... the prices of certain Medicare Part D prescription drugs ... and epilepsy – at CVS and Walgreens pharmacies.  The ... to pay significantly more for their drugs than they ...
Cached Medicine Technology:Biosyntrx, Inc. Appoints New Board Member & New VP of Operations 2CVS Caremark Corporation Settles FTC Deceptive Pricing Charges 2CVS Caremark Corporation Settles FTC Deceptive Pricing Charges 3CVS Caremark Corporation Settles FTC Deceptive Pricing Charges 4
(Date:4/24/2014)... The University of Manchester have identified a way to ... open to treatment. , The study published today in ... the development of drugs to target cells that have ... the discovery whilst exploring the possible mechanisms behind resistance ... breast and colon cancer. , Dr Andrew Gilmore, who ...
(Date:4/24/2014)... April 24, 2014 ,Take me out to ... slices and kale chips. The more likely culprits include ... , Unfortunately for children who play youth baseball, ... contributing to weight problems, according to researchers at Wake ... current online edition of Childhood Obesity , found ...
(Date:4/24/2014)... and the relevance of palliation in advanced cancer ... controlled trials (RCTs). This is the result of ... and Efficiency in Health Care (IQWiG), which has ... with external experts, IQWiG analysed studies on four ... melanoma, and pancreatic cancer. For this purpose, the ...
(Date:4/24/2014)... has been awarded one of 30 grants from the ... Academic Participating Site in its new National Clinical ... select groups of investigators charged with distributing resources in ... NCTN grant system reflects recommendations from a 2010 ... achieve four goals:, Faster design, launch, and ...
(Date:4/23/2014)... (MGH) investigators may lead to greater availability and acceptability ... use of fecal material from healthy donors to ... ( C. difficile ) bacteria. In their ... Infectious Diseases , the researchers report that use of ... was as successful in curing recurrent C. difficile ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Take the bat, leave the candy 2Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3
... ... Deepak Chopra and Dr. David Simon have expanded upon their extensive line of ... body. Enjoy and share the benefits of the age-old wisdom and timeless healing ... Guide and find the perfect gift that shows you care and helps transform ...
... nearly four billion people living in 47 different countries, and ... health issues. But when they come to the United States, ... Health researchers say this makes it difficult to learn ... one of the leading killers of Asian-Americans. "There is ...
... 2009) Findings from a new retrospective cohort ... Annual Scientific meeting in San Diego indicate that patients ... thiopurine class of medications to treat IBD, may be ... Dr. Millie Long, of the University of North Carolina, ...
... In two new studies, presented at the American College ... Diego, researchers explored the connection between high stress, high ... performed by the United States Navy and the State ... term effects of infectious gastroenteritis (IGE) among active duty ...
... , ARLINGTON, Va., Oct. 29 The American Chemistry Council ... EPA and published online yesterday in the journal Toxicological Sciences. ... and ethinyl estradiol (EE2)in utero in a wide range of doses ... be attributed to Steven G. Hentges, Ph.D., ACC,s Polycarbonate/BPA ...
... Consumer Watchdog sent the following letter to Congressional leaders ... Governor Arnold Schwarzenegger in which he incorrectly cited California,s ... as a successful cost containment tool. Consumer Watchdog ... Washington, D.C. The Governor,s October 27, 2009 letter ...
Cached Medicine News:Health News:The Chopra Center for Wellbeing Online Holiday Gift Guide -- Gifts that Make a Difference 2Health News:The Chopra Center for Wellbeing Online Holiday Gift Guide -- Gifts that Make a Difference 3Health News:1 disease, not 1 demographic 2Health News:1 disease, not 1 demographic 3Health News:Study reveals possible link between IBD therapy and skin cancer 2Health News:New studies explore connection between high stress jobs and GI disorders 2Health News:New studies explore connection between high stress jobs and GI disorders 3Health News:New EPA Rodent Study Finds No Low-Dose BPA Effects on Reproductive Function or Behavior 2Health News:Consumer Group Responds to Governor Schwarzenegger's Incorrect Claims About the Impact of Medical Malpractice Caps 2Health News:Consumer Group Responds to Governor Schwarzenegger's Incorrect Claims About the Impact of Medical Malpractice Caps 3
... Original Knee Brace gives fracture treatment patients ... control, this brace features the the Bledsoe ... from 0-120, and positively locks at any ... eccentric cam slots, the Bledsoe Multi-Centric Hinge ...
The Bledsoe Post-Op Knee Brace is designed to provide maximum protection without sacrificing comfort and quick, easy application....
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: